LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 22 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $61,701,000 | +28.1% | 17,500,000 | 0.0% | 0.34% | +15.3% |
| Q2 2018 | $48,149,000 | +25.8% | 17,500,000 | 0.0% | 0.29% | +18.1% |
| Q1 2018 | $38,265,000 | +67.0% | 17,500,000 | +40.0% | 0.25% | +112.8% |
| Q4 2017 | $22,910,000 | +0.5% | 12,500,000 | 0.0% | 0.12% | -33.5% |
| Q3 2017 | $22,799,000 | +9.7% | 12,500,000 | 0.0% | 0.18% | +14.3% |
| Q2 2017 | $20,783,000 | +10.9% | 12,500,000 | 0.0% | 0.15% | +4.8% |
| Q1 2017 | $18,732,000 | +85.2% | 12,500,000 | +78.6% | 0.15% | +83.8% |
| Q4 2016 | $10,116,000 | -1.4% | 7,000,000 | 0.0% | 0.08% | +9.6% |
| Q3 2016 | $10,263,000 | -13.4% | 7,000,000 | 0.0% | 0.07% | -12.0% |
| Q2 2016 | $11,855,000 | +10.9% | 7,000,000 | 0.0% | 0.08% | +16.9% |
| Q1 2016 | $10,692,000 | -1.8% | 7,000,000 | 0.0% | 0.07% | +2.9% |
| Q4 2015 | $10,893,000 | +20.0% | 7,000,000 | 0.0% | 0.07% | +9.5% |
| Q3 2015 | $9,074,000 | – | 7,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mint Tower Capital Management B.V. | 12,000,000 | $19,882,000 | 4.94% |
| CQS Cayman LP | 25,000,000 | $41,458,000 | 2.86% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,245,000 | $20,273,000 | 2.64% |
| TFG Asset Management GP Ltd | 6,100,000 | $10,116,000 | 1.50% |
| CSS LLC/IL | 11,490,000 | $19,090,000 | 0.93% |
| ANGELO GORDON & CO., L.P. | 8,500,000 | $14,068,000 | 0.69% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,500,000 | $45,566,000 | 0.68% |
| Verition Fund Management LLC | 3,200,000 | $5,312,000 | 0.52% |
| SHENKMAN CAPITAL MANAGEMENT INC | 2,932,000 | $4,867,000 | 0.44% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $7,962,000 | 0.30% |